*Please note that we are no longer accepting clients for Zofran claims
Zofran Linked to Birth Defects
Zofran (ondansetron) is a commonly prescribed medication to treat morning sickness and nausea in pregnant women. The use of Zofran in pregnant women is considered an “off-label” use because it was never approved by the FDA to treat pregnant women.
If you have taken Zofran during pregnancy and your child has birth defects, immediately seek legal advice from Shapiro Legal Group, PLLC. Our Zofran lawsuit lawyer will carefully examine your case if you are entitled to compensation. Contact us today online or by calling (888)640-DRUG.
Why Choose Us for Your Zofran Lawsuit Lawyer?
- Mark Shapiro has been a mass tort lawyer handling tort cases, such as Zofran, for over two decades.
- Our Zofran attorney only specializes in mass tort litigation, giving us insight and specialized knowledge to handle your case.
- At Shapiro Legal Group, PLLC, we ensure that any negligent parties are held responsible for your injuries by pursuing the maximum possible compensation you need to make a full recovery.
Types of Birth Defects Linked to Zofran
Several studies have linked Zofran use during pregnancy to birth defects. If you took Zofran during pregnancy and your child was diagnosed with any of the following birth defects, you may be entitled to compensation:
- Cleft Palate
- Cleft Lip
- Ventricular Septal Defect (VSD)
- Atrial Septal Defect (ASD)
- Neural Tube Defects
- Musculoskeletal Deformities
- $2 Billion Settlement
In 2012 GlaxoSmithKline, the manufacturer of Zofran, agreed to a $2 billion civil settlement after the United States Department of Justice alleged they paid illegally marketed Zofran to expectant mothers for off-label uses. According to the Department of Justice press release, “GSK promoted certain forms of Zofran, approved only for post-operative nausea, for the treatment of morning sickness in pregnant women. It also includes allegations that GSK paid kickbacks to health care professionals to induce them to promote and prescribe these drugs.” GlaxoSmithKline has since changed the warning label to include “The use of ondansetron in pregnancy is not recommended.”